Report Detail

Request for Sample of this report

Pharma & Healthcare Global Large Animals Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4600948
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 133 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Large Animals Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
The Global Info Research report includes an overview of the development of the Large Animals Drugs industry chain, the market status of Veterinary Hospitals (Molecular Diagnostics, Immunodiagnostics), Veterinary Clinics (Molecular Diagnostics, Immunodiagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Large Animals Drugs.
Regionally, the report analyzes the Large Animals Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Large Animals Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Large Animals Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Large Animals Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Molecular Diagnostics, Immunodiagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Large Animals Drugs market.
Regional Analysis: The report involves examining the Large Animals Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Large Animals Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Large Animals Drugs:
Company Analysis: Report covers individual Large Animals Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Large Animals Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Veterinary Hospitals, Veterinary Clinics).
Technology Analysis: Report covers specific technologies relevant to Large Animals Drugs. It assesses the current state, advancements, and potential future developments in Large Animals Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Large Animals Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Large Animals Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Molecular Diagnostics
Immunodiagnostics
Market segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
Market segment by players, this report covers
Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Large Animals Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Large Animals Drugs, with revenue, gross margin and global market share of Large Animals Drugs from 2019 to 2024.
Chapter 3, the Large Animals Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Large Animals Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Large Animals Drugs.
Chapter 13, to describe Large Animals Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Large Animals Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Large Animals Drugs by Type
    • 1.3.1 Overview: Global Large Animals Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Large Animals Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Molecular Diagnostics
    • 1.3.4 Immunodiagnostics
  • 1.4 Global Large Animals Drugs Market by Application
    • 1.4.1 Overview: Global Large Animals Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Veterinary Hospitals
    • 1.4.3 Veterinary Clinics
    • 1.4.4 Others
  • 1.5 Global Large Animals Drugs Market Size & Forecast
  • 1.6 Global Large Animals Drugs Market Size and Forecast by Region
    • 1.6.1 Global Large Animals Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Large Animals Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Large Animals Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Large Animals Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Large Animals Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Large Animals Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Large Animals Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Boehringer Ingelheim
    • 2.1.1 Boehringer Ingelheim Details
    • 2.1.2 Boehringer Ingelheim Major Business
    • 2.1.3 Boehringer Ingelheim Large Animals Drugs Product and Solutions
    • 2.1.4 Boehringer Ingelheim Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.2 Zoetis
    • 2.2.1 Zoetis Details
    • 2.2.2 Zoetis Major Business
    • 2.2.3 Zoetis Large Animals Drugs Product and Solutions
    • 2.2.4 Zoetis Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Zoetis Recent Developments and Future Plans
  • 2.3 IDEXX Laboratories
    • 2.3.1 IDEXX Laboratories Details
    • 2.3.2 IDEXX Laboratories Major Business
    • 2.3.3 IDEXX Laboratories Large Animals Drugs Product and Solutions
    • 2.3.4 IDEXX Laboratories Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 IDEXX Laboratories Recent Developments and Future Plans
  • 2.4 Elanco Animal Health
    • 2.4.1 Elanco Animal Health Details
    • 2.4.2 Elanco Animal Health Major Business
    • 2.4.3 Elanco Animal Health Large Animals Drugs Product and Solutions
    • 2.4.4 Elanco Animal Health Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Elanco Animal Health Recent Developments and Future Plans
  • 2.5 Bayer Animal Health
    • 2.5.1 Bayer Animal Health Details
    • 2.5.2 Bayer Animal Health Major Business
    • 2.5.3 Bayer Animal Health Large Animals Drugs Product and Solutions
    • 2.5.4 Bayer Animal Health Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bayer Animal Health Recent Developments and Future Plans
  • 2.6 Merck Animal Health
    • 2.6.1 Merck Animal Health Details
    • 2.6.2 Merck Animal Health Major Business
    • 2.6.3 Merck Animal Health Large Animals Drugs Product and Solutions
    • 2.6.4 Merck Animal Health Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck Animal Health Recent Developments and Future Plans
  • 2.7 Dechra Veterinary Products
    • 2.7.1 Dechra Veterinary Products Details
    • 2.7.2 Dechra Veterinary Products Major Business
    • 2.7.3 Dechra Veterinary Products Large Animals Drugs Product and Solutions
    • 2.7.4 Dechra Veterinary Products Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Dechra Veterinary Products Recent Developments and Future Plans
  • 2.8 Parnell
    • 2.8.1 Parnell Details
    • 2.8.2 Parnell Major Business
    • 2.8.3 Parnell Large Animals Drugs Product and Solutions
    • 2.8.4 Parnell Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Parnell Recent Developments and Future Plans
  • 2.9 Abaxis
    • 2.9.1 Abaxis Details
    • 2.9.2 Abaxis Major Business
    • 2.9.3 Abaxis Large Animals Drugs Product and Solutions
    • 2.9.4 Abaxis Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Abaxis Recent Developments and Future Plans
  • 2.10 Virbac
    • 2.10.1 Virbac Details
    • 2.10.2 Virbac Major Business
    • 2.10.3 Virbac Large Animals Drugs Product and Solutions
    • 2.10.4 Virbac Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Virbac Recent Developments and Future Plans
  • 2.11 Ceva
    • 2.11.1 Ceva Details
    • 2.11.2 Ceva Major Business
    • 2.11.3 Ceva Large Animals Drugs Product and Solutions
    • 2.11.4 Ceva Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Ceva Recent Developments and Future Plans
  • 2.12 Meiji
    • 2.12.1 Meiji Details
    • 2.12.2 Meiji Major Business
    • 2.12.3 Meiji Large Animals Drugs Product and Solutions
    • 2.12.4 Meiji Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Meiji Recent Developments and Future Plans
  • 2.13 Vetoquinol
    • 2.13.1 Vetoquinol Details
    • 2.13.2 Vetoquinol Major Business
    • 2.13.3 Vetoquinol Large Animals Drugs Product and Solutions
    • 2.13.4 Vetoquinol Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Vetoquinol Recent Developments and Future Plans
  • 2.14 Ouro Fino Saude
    • 2.14.1 Ouro Fino Saude Details
    • 2.14.2 Ouro Fino Saude Major Business
    • 2.14.3 Ouro Fino Saude Large Animals Drugs Product and Solutions
    • 2.14.4 Ouro Fino Saude Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Ouro Fino Saude Recent Developments and Future Plans
  • 2.15 Animalcare Group
    • 2.15.1 Animalcare Group Details
    • 2.15.2 Animalcare Group Major Business
    • 2.15.3 Animalcare Group Large Animals Drugs Product and Solutions
    • 2.15.4 Animalcare Group Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Animalcare Group Recent Developments and Future Plans
  • 2.16 IDvet
    • 2.16.1 IDvet Details
    • 2.16.2 IDvet Major Business
    • 2.16.3 IDvet Large Animals Drugs Product and Solutions
    • 2.16.4 IDvet Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 IDvet Recent Developments and Future Plans
  • 2.17 Shenzhen Mindray Bio-Medical
    • 2.17.1 Shenzhen Mindray Bio-Medical Details
    • 2.17.2 Shenzhen Mindray Bio-Medical Major Business
    • 2.17.3 Shenzhen Mindray Bio-Medical Large Animals Drugs Product and Solutions
    • 2.17.4 Shenzhen Mindray Bio-Medical Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Shenzhen Mindray Bio-Medical Recent Developments and Future Plans
  • 2.18 Bio-Rad Laboratories
    • 2.18.1 Bio-Rad Laboratories Details
    • 2.18.2 Bio-Rad Laboratories Major Business
    • 2.18.3 Bio-Rad Laboratories Large Animals Drugs Product and Solutions
    • 2.18.4 Bio-Rad Laboratories Large Animals Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Bio-Rad Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Large Animals Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Large Animals Drugs by Company Revenue
    • 3.2.2 Top 3 Large Animals Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Large Animals Drugs Players Market Share in 2023
  • 3.3 Large Animals Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Large Animals Drugs Market: Region Footprint
    • 3.3.2 Large Animals Drugs Market: Company Product Type Footprint
    • 3.3.3 Large Animals Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Large Animals Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Large Animals Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Large Animals Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Large Animals Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Large Animals Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Large Animals Drugs Consumption Value by Application (2019-2030)
  • 6.3 North America Large Animals Drugs Market Size by Country
    • 6.3.1 North America Large Animals Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Large Animals Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Large Animals Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Large Animals Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Large Animals Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Large Animals Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Large Animals Drugs Market Size by Country
    • 7.3.1 Europe Large Animals Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Large Animals Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Large Animals Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Large Animals Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Large Animals Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Large Animals Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Large Animals Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Large Animals Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Large Animals Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Large Animals Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Large Animals Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Large Animals Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Large Animals Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Large Animals Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Large Animals Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Large Animals Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Large Animals Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Large Animals Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Large Animals Drugs Market Size by Country
    • 9.3.1 South America Large Animals Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Large Animals Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Large Animals Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Large Animals Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Large Animals Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Large Animals Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Large Animals Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Large Animals Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Large Animals Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Large Animals Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Large Animals Drugs Market Drivers
  • 11.2 Large Animals Drugs Market Restraints
  • 11.3 Large Animals Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Large Animals Drugs Industry Chain
  • 12.2 Large Animals Drugs Upstream Analysis
  • 12.3 Large Animals Drugs Midstream Analysis
  • 12.4 Large Animals Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Large Animals Drugs. Industry analysis & Market Report on Large Animals Drugs is a syndicated market report, published as Global Large Animals Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Large Animals Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,641.32
    		3,961.98
    		5,282.64
    		3,128.52
    		4,692.78
    		6,257.04
    		492,802.80
    		739,204.20
    		985,605.60
    		291,728.40
    		437,592.60
    		583,456.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo